An exploratory integrative analysis of plasma transcriptomic and proteomic predictors of response to total neoadjuvant therapy in locally advanced rectal cancer - Top-Institutions - MDSpire

An exploratory integrative analysis of plasma transcriptomic and proteomic predictors of response to total neoadjuvant therapy in locally advanced rectal cancer

  • By

  • Zonglin Zhu

  • Kaizhen Wen

  • Baoyi Zou

  • Yanhua Kang

  • Jingqing Chen

  • Bin Zhu

  • Liping Fan

  • Haobo Huang

  • June 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Fujian Medical University Union Hospital
    Fujian Medical University Union Hospital

    Fuzhou, Fujian

    Key Differentiators

    • Oncology

  • #2

    Akershus University Hospital
    Akershus University Hospital

    Lillestrøm, Viken

    Key Differentiators

    • Oncology

  • #3

    Det Norske Radiumhospital
    Det Norske Radiumhospital

    Oslo, Oslo

    Key Differentiators

    • Oncology

  • #4

    Sixth Affiliated Hospital, Sun Yat-sen University
    Sixth Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology

  • #5

    The First Hospital of Lanzhou University
    The First Hospital of Lanzhou University

    Lanzhou, Gansu

    Key Differentiators

    • Oncology

Original Source(s)

An exploratory integrative analysis of plasma transcriptomic and proteomic predictors of response to total neoadjuvant therapy in locally advanced rectal cancer

  • by Zonglin Zhu, Kaizhen Wen, Baoyi Zou, Yanhua Kang, Jingqing Chen, Bin Zhu, Liping Fan, Haobo Huang

  • June 8, 2026

Related Content

Lobectomy versus sublobar resection for stage I non-small cell lung cancer: an umbrella review of evidence quality, overlap, surgical-extent heterogeneity, and survival outcomes

Recurrent intracranial hemorrhage without brain metastasis after VEGFR TKI rechallenge in metastatic renal cell carcinoma: a case report and literature review

D-VRD induction and autologous transplant in patients ≥70 years